On September 14, 2023, Aprogen Medicines Inc. closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,304 KRW | +1.72% | -5.71% | +35.83% |
05-14 | Aprogen Medicines Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
03-19 | Aprogen Medicines Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
+35.83% | 237M | |
-16.20% | 10.37B | |
+6.21% | 5.56B | |
+0.48% | 3.01B | |
-21.83% | 2.18B | |
-19.51% | 1.47B | |
+0.57% | 1.09B | |
-43.66% | 735M | |
-29.00% | 679M | |
-4.12% | 489M |
- Stock Market
- Equities
- A007460 Stock
- News Aprogen Medicines Inc.
- Aprogen Medicines Inc. announced that it has received KRW 70 billion in funding